Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells

Hiroshi Aoki, Eiji Iwado, Mark S. Eller, Yasuko Kondo, Keishi Fujiwara, Guang Zhi Li, Kenneth R. Hess, Doris R. Siwak, Raymond Sawaya, Gordon Mills, Barbara A. Gilchrest, Seiji Kondo

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Telomere 3′ overhang-specific DNA oligonucleotides (T-oligos) induce cell death in cancer cells, presumably by mimicking telomere loop disruption. Therefore, T-oligos are considered an exciting new therapeutic strategy. The purpose of this study was to elucidate how T-oligos exert antitumor effects on human malignant glioma cells in vitro and in vivo. We demonstrated that T-oligos inhibited the proliferation of malignant glioma cells through induction of nonapoptotic cell death and mitochondria hyperpolarization, whereas normal astrocytes were resistant to T-oligos. Tumor cells treated with T-oligos developed features compatible with autophagy, with development of autophagic vacuoles and conversion of an autophagy-related protein, microtubule-associated protein 1 light chain 3 from type I (cytoplasmic form) to type II (membrane form of autophagic vacuoles). A reversephase protein microarray analysis and Western blotting revealed that treatment with T-oligos inhibited the mammalian target of the rapamycin (mTOR) and the signal transducer and activator of transcription 3 (STAT3). Moreover, pretreatment with T-oligos significantly prolonged the survival time of mice inoculated intracranially with malignant glioma cells compared with that of untreated mice and those treated with control oligonucleotides (P=0.0065 and P=0.043, respectively). These results indicate that T-oligos stimulate the induction of nonapoptotic autophagic also known as type II programmed cell death and are thus promising in the treatment of malignant glioma.

Original languageEnglish (US)
Pages (from-to)2918-2930
Number of pages13
JournalFASEB Journal
Volume21
Issue number11
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

Telomere
Autophagy
Cell death
Glioma
Oligonucleotides
DNA
Cells
STAT3 Transcription Factor
Vacuoles
Mitochondria
Microtubule-Associated Proteins
Sirolimus
Microarrays
Cell Death
Tumors
Protein Array Analysis
Proteins
Membranes
Astrocytes
Neoplasms

Keywords

  • mTOR
  • T-oligos

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Aoki, H., Iwado, E., Eller, M. S., Kondo, Y., Fujiwara, K., Li, G. Z., ... Kondo, S. (2007). Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB Journal, 21(11), 2918-2930. https://doi.org/10.1096/fj.06-6941com

Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. / Aoki, Hiroshi; Iwado, Eiji; Eller, Mark S.; Kondo, Yasuko; Fujiwara, Keishi; Li, Guang Zhi; Hess, Kenneth R.; Siwak, Doris R.; Sawaya, Raymond; Mills, Gordon; Gilchrest, Barbara A.; Kondo, Seiji.

In: FASEB Journal, Vol. 21, No. 11, 01.09.2007, p. 2918-2930.

Research output: Contribution to journalArticle

Aoki, H, Iwado, E, Eller, MS, Kondo, Y, Fujiwara, K, Li, GZ, Hess, KR, Siwak, DR, Sawaya, R, Mills, G, Gilchrest, BA & Kondo, S 2007, 'Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells', FASEB Journal, vol. 21, no. 11, pp. 2918-2930. https://doi.org/10.1096/fj.06-6941com
Aoki, Hiroshi ; Iwado, Eiji ; Eller, Mark S. ; Kondo, Yasuko ; Fujiwara, Keishi ; Li, Guang Zhi ; Hess, Kenneth R. ; Siwak, Doris R. ; Sawaya, Raymond ; Mills, Gordon ; Gilchrest, Barbara A. ; Kondo, Seiji. / Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. In: FASEB Journal. 2007 ; Vol. 21, No. 11. pp. 2918-2930.
@article{9f8377ce417340a9830c12aa88dbc906,
title = "Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells",
abstract = "Telomere 3′ overhang-specific DNA oligonucleotides (T-oligos) induce cell death in cancer cells, presumably by mimicking telomere loop disruption. Therefore, T-oligos are considered an exciting new therapeutic strategy. The purpose of this study was to elucidate how T-oligos exert antitumor effects on human malignant glioma cells in vitro and in vivo. We demonstrated that T-oligos inhibited the proliferation of malignant glioma cells through induction of nonapoptotic cell death and mitochondria hyperpolarization, whereas normal astrocytes were resistant to T-oligos. Tumor cells treated with T-oligos developed features compatible with autophagy, with development of autophagic vacuoles and conversion of an autophagy-related protein, microtubule-associated protein 1 light chain 3 from type I (cytoplasmic form) to type II (membrane form of autophagic vacuoles). A reversephase protein microarray analysis and Western blotting revealed that treatment with T-oligos inhibited the mammalian target of the rapamycin (mTOR) and the signal transducer and activator of transcription 3 (STAT3). Moreover, pretreatment with T-oligos significantly prolonged the survival time of mice inoculated intracranially with malignant glioma cells compared with that of untreated mice and those treated with control oligonucleotides (P=0.0065 and P=0.043, respectively). These results indicate that T-oligos stimulate the induction of nonapoptotic autophagic also known as type II programmed cell death and are thus promising in the treatment of malignant glioma.",
keywords = "mTOR, T-oligos",
author = "Hiroshi Aoki and Eiji Iwado and Eller, {Mark S.} and Yasuko Kondo and Keishi Fujiwara and Li, {Guang Zhi} and Hess, {Kenneth R.} and Siwak, {Doris R.} and Raymond Sawaya and Gordon Mills and Gilchrest, {Barbara A.} and Seiji Kondo",
year = "2007",
month = "9",
day = "1",
doi = "10.1096/fj.06-6941com",
language = "English (US)",
volume = "21",
pages = "2918--2930",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "11",

}

TY - JOUR

T1 - Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells

AU - Aoki, Hiroshi

AU - Iwado, Eiji

AU - Eller, Mark S.

AU - Kondo, Yasuko

AU - Fujiwara, Keishi

AU - Li, Guang Zhi

AU - Hess, Kenneth R.

AU - Siwak, Doris R.

AU - Sawaya, Raymond

AU - Mills, Gordon

AU - Gilchrest, Barbara A.

AU - Kondo, Seiji

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Telomere 3′ overhang-specific DNA oligonucleotides (T-oligos) induce cell death in cancer cells, presumably by mimicking telomere loop disruption. Therefore, T-oligos are considered an exciting new therapeutic strategy. The purpose of this study was to elucidate how T-oligos exert antitumor effects on human malignant glioma cells in vitro and in vivo. We demonstrated that T-oligos inhibited the proliferation of malignant glioma cells through induction of nonapoptotic cell death and mitochondria hyperpolarization, whereas normal astrocytes were resistant to T-oligos. Tumor cells treated with T-oligos developed features compatible with autophagy, with development of autophagic vacuoles and conversion of an autophagy-related protein, microtubule-associated protein 1 light chain 3 from type I (cytoplasmic form) to type II (membrane form of autophagic vacuoles). A reversephase protein microarray analysis and Western blotting revealed that treatment with T-oligos inhibited the mammalian target of the rapamycin (mTOR) and the signal transducer and activator of transcription 3 (STAT3). Moreover, pretreatment with T-oligos significantly prolonged the survival time of mice inoculated intracranially with malignant glioma cells compared with that of untreated mice and those treated with control oligonucleotides (P=0.0065 and P=0.043, respectively). These results indicate that T-oligos stimulate the induction of nonapoptotic autophagic also known as type II programmed cell death and are thus promising in the treatment of malignant glioma.

AB - Telomere 3′ overhang-specific DNA oligonucleotides (T-oligos) induce cell death in cancer cells, presumably by mimicking telomere loop disruption. Therefore, T-oligos are considered an exciting new therapeutic strategy. The purpose of this study was to elucidate how T-oligos exert antitumor effects on human malignant glioma cells in vitro and in vivo. We demonstrated that T-oligos inhibited the proliferation of malignant glioma cells through induction of nonapoptotic cell death and mitochondria hyperpolarization, whereas normal astrocytes were resistant to T-oligos. Tumor cells treated with T-oligos developed features compatible with autophagy, with development of autophagic vacuoles and conversion of an autophagy-related protein, microtubule-associated protein 1 light chain 3 from type I (cytoplasmic form) to type II (membrane form of autophagic vacuoles). A reversephase protein microarray analysis and Western blotting revealed that treatment with T-oligos inhibited the mammalian target of the rapamycin (mTOR) and the signal transducer and activator of transcription 3 (STAT3). Moreover, pretreatment with T-oligos significantly prolonged the survival time of mice inoculated intracranially with malignant glioma cells compared with that of untreated mice and those treated with control oligonucleotides (P=0.0065 and P=0.043, respectively). These results indicate that T-oligos stimulate the induction of nonapoptotic autophagic also known as type II programmed cell death and are thus promising in the treatment of malignant glioma.

KW - mTOR

KW - T-oligos

UR - http://www.scopus.com/inward/record.url?scp=34548497874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548497874&partnerID=8YFLogxK

U2 - 10.1096/fj.06-6941com

DO - 10.1096/fj.06-6941com

M3 - Article

VL - 21

SP - 2918

EP - 2930

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 11

ER -